Federal law divides controlled substances into five categories called drug schedules 1 through 5, ranked by abuse potential, accepted medical use, and safety. Schedule I is the most restrictive and covers drugs the government treats as having no legitimate medical purpose. Schedule V is the least restrictive and covers preparations with the lowest abuse risk. The schedule a substance sits in decides whether a doctor can prescribe it, how a pharmacy can refill it, and how harshly a court can punish someone caught with it or selling it.
Schedule I
A drug lands in Schedule I only when all three conditions are met: high potential for abuse, no currently accepted medical use in the United States, and no accepted safe use even under medical supervision.1Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances Doctors cannot prescribe these substances. The only lawful access is through research conducted under a special DEA registration.
Common Schedule I drugs include heroin, LSD, MDMA (ecstasy), psilocybin, peyote, and marijuana.2Drug Enforcement Administration. Drug Scheduling Marijuana’s placement here remains the most contested classification in the system, and a rescheduling proceeding is underway (see below).
Schedule II
Schedule II drugs share Schedule I’s high abuse potential but have a currently accepted medical use, usually with severe restrictions.3Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances They are the substances most likely to cause severe physical or psychological dependence, and the DEA sets annual production quotas capping how much manufacturers can make.
The category covers some of the most-prescribed and most-abused medications in the country: oxycodone (OxyContin), fentanyl, morphine, methamphetamine, cocaine (still used in limited medical settings as a local anesthetic), hydrocodone combination products, and stimulants like Adderall and Ritalin.2Drug Enforcement Administration. Drug Scheduling
Schedule III
Schedule III drugs have a lower abuse potential than Schedule I or II. They carry an accepted medical use and may cause moderate physical dependence or high psychological dependence.3Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances
Examples include combination products containing no more than 90 milligrams of codeine per dose, anabolic steroids, ketamine, and certain barbiturates. Testosterone and other anabolic steroids were placed here because of widespread misuse in athletics, even though the pattern differs from opioid or stimulant abuse.
Schedule IV
Schedule IV drugs have a low abuse potential relative to Schedule III, a recognized medical use, and produce only limited dependence when misused.3Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances
Benzodiazepines dominate this tier: alprazolam (Xanax), diazepam (Valium), clonazepam (Klonopin), and lorazepam (Ativan). Sleep medications like zolpidem (Ambien) and the muscle relaxant carisoprodol also belong here. The “low abuse potential” label describes where these drugs sit relative to the others; benzodiazepine dependence is still a serious clinical problem.
Schedule V
Schedule V is the lowest tier of federal control. It covers preparations containing small amounts of narcotics, typically for cough or diarrhea, with cough syrups containing limited codeine concentrations as the classic example. These drugs have the lowest abuse potential and minimal dependence risk in the scheduling system.3Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances Some Schedule V products may be available without a prescription in certain states, though federal regulations still apply.
Prescription and Refill Rules by Schedule
The schedule a drug sits in directly controls how a doctor can prescribe it and how a pharmacy can fill it. The rules tighten as you move up.
Schedule II
Federal law does not permit refills of Schedule II prescriptions. Each fill requires a new prescription. There is no federal cap on the quantity a doctor can order at once, but the pharmacist has a professional duty to verify the prescription serves a legitimate medical purpose. If the pharmacy cannot supply the full quantity, the remainder must be dispensed within 72 hours or the pharmacist must contact the prescriber, and any unfilled portion after that requires a new prescription.4eCFR. 21 CFR 1306.13 – Partial Filling of Prescriptions
Schedules III and IV
Prescriptions for Schedule III and IV drugs can be refilled up to five times within six months of the original prescription date. After five refills or six months, whichever comes first, the patient needs a new prescription.5Office of the Law Revision Counsel. 21 USC 829 – Prescriptions
Schedule V
Schedule V drugs follow similar refill rules, and some states allow pharmacists to dispense certain Schedule V preparations without a prescription. State law often adds restrictions on top of these federal baselines.
Federal Penalties by Schedule
Federal drug penalties split into two tracks: simple possession for personal use, and trafficking, which covers manufacturing, distributing, or dispensing. The sentencing ranges are worlds apart.
Simple Possession
A first offense for simple possession of any controlled substance, regardless of schedule, carries up to one year in prison and a minimum fine of $1,000.6Office of the Law Revision Counsel. 21 USC 844 – Penalties for Simple Possession A conviction can also trigger forfeiture of property used in the offense, loss of eligibility for federal benefits including student loans, and denial of professional licenses.
Trafficking
For Schedule I and II drugs, penalties depend on both the substance and the quantity. Three tiers apply:
- Large quantities (for example, 1 kilogram or more of heroin, or 5 kilograms or more of cocaine): first offense carries a mandatory minimum of 10 years up to life, with individual fines up to $10 million.
- Mid-range quantities (for example, 100 grams to 1 kilogram of heroin, or 500 grams to 5 kilograms of cocaine): first offense carries a mandatory minimum of 5 years up to 40 years, with individual fines up to $5 million.
- Any other amount: first offense carries up to 20 years with no mandatory minimum, and individual fines up to $1 million. If a death or serious injury results from the drug, the mandatory minimum rises to 20 years.
Those mandatory minimums are a floor, and a judge can reduce them only in narrow circumstances.7Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A
Penalties for the lower schedules do not depend on quantity:
- Schedule III: up to 10 years in prison and individual fines up to $500,000.
- Schedule IV: up to 5 years in prison and individual fines up to $250,000.
- Schedule V: up to 1 year in prison and individual fines up to $100,000.
Second and subsequent offenses roughly double these ranges across all schedules.7Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A
How Drugs Move Between Schedules
The list is not fixed. The DEA, the Department of Health and Human Services, or any interested party (including drug manufacturers, medical associations, state governments, and private citizens) can petition to add, remove, or reclassify a substance.8Drug Enforcement Administration. The Controlled Substances Act The Attorney General must first request a scientific and medical evaluation from HHS, whose findings on medical use and abuse potential bind the DEA at the proposal stage. A public comment period and a final DEA rule follow.9Office of the Law Revision Counsel. 21 USC 811 – Authority and Criteria for Classification of Substances
Emergency Temporary Scheduling
When a new substance poses an imminent hazard, the Attorney General can place it in Schedule I temporarily without the full HHS evaluation. A temporary order lasts two years and can be extended one additional year while permanent scheduling is worked out.10Office of the Law Revision Counsel. 21 USC 811 – Authority and Criteria for Classification of Substances The DEA used this authority in March 2026 to temporarily schedule bromazolam, a designer benzodiazepine linked to overdose deaths.11Federal Register. Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
The Marijuana Rescheduling Proceeding
The most closely watched rescheduling effort in decades involves marijuana. After HHS recommended reclassification, the DEA proposed moving marijuana from Schedule I to Schedule III. The agency withdrew its original hearing proceedings in early 2026 and launched an expedited process, with an administrative hearing set for June 29, 2026.12U.S. Department of Justice. Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Until a final rule is published, marijuana remains a Schedule I substance under federal law regardless of how any state treats it. A final rescheduling would give marijuana a recognized federal medical use, ease research restrictions, and drop federal penalties to the Schedule III tier. It would not legalize recreational marijuana at the federal level.
A Note on Analogues
The five schedules do not capture every substance that federal law reaches. Under the Controlled Substance Analogue Enforcement Act, a substance whose chemical structure and effects on the central nervous system are substantially similar to a Schedule I or II drug, and which is intended for human consumption, is treated as a Schedule I substance.13Office of the Law Revision Counsel. 21 USC 813 – Treatment of Controlled Substance Analogues Labels like “bath salts,” “plant food,” or “not for human consumption” do not provide legal cover if prosecutors can show the product was actually meant to be ingested. So a drug not appearing on any of the five schedules is not automatically legal.